Sample, data use and protection in biobanking in Europe: legal issuesMeta-analysis in genome-wide association studiesCYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosingCollaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomicsThe epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomicsSerotonergic gene variation in substance use pharmacotherapy: a systematic reviewUsing large-scale genomics data to identify driver mutations in lung cancer: methods and challengesImpact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infectionTowards a personalized treatment in depression: endocannabinoids, inflammation and stress responseIntegrative systems biology approaches in asthma pharmacogenomicsIn vitro human cell line models to predict clinical response to anticancer drugsPharmacogenetics-based warfarin dosing in childrenClinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementationThe clinically relevant pharmacogenomic changes in acute myelogenous leukemiaHuman OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areasG>C SNP of thymidylate synthase with respect to colorectal cancer.Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityPharmacogenomics and drug response in cardiovascular disordersCommon variations in platelet glycoproteins: pharmacogenomic implicationsPharmacogenomic considerations of the paraoxonase polymorphismsFrequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirinRecent progress in multiple sequence alignment: a surveyGenetic network modelingCysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patientsInfluence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipientsPolymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaAsthma pharmacogenetic study using finite mixture models to handle drug-response heterogeneityImpact of apolipoprotein A5 variants on statin treatment efficacyPharmacogenetics of erectile dysfunction: navigating into uncharted watersFunctionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsRamping it up: RAMP1 and the implications for migraineHuman Variome Project: an international collaboration to catalogue human genetic variationCommon sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statinsIconix Pharmaceuticals, Inc.--removing barriers to efficient drug discovery through chemogenomicsIrinotecan pharmacogenomicsInfluence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patientsKey aspects of analyzing microarray gene-expression dataGenetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectivesSemantically enabling pharmacogenomic data for the realization of personalized medicine
P1433
Q22330783-90656E53-760A-4FE1-A2DE-A869196E5793Q24273398-61EDE985-DB77-49AF-8E00-321905CF28DCQ24641999-64D9FF4A-C349-42CC-AECB-F7FDED52392DQ24645892-08AC7907-A707-4EDE-B6D1-F074EF338728Q26785674-572DFA67-406B-4D6B-A73D-F159344D7465Q26799093-60F52EE3-464C-449E-9300-111CF4E6C82CQ26800833-91B4B67B-D50B-42B6-B427-352E3169DBF0Q26801381-8A1E69A4-C33F-4257-AB2B-A6E2AAB7049FQ26851511-C4D14E88-A98C-4F19-90BB-42083F6C54A6Q26861541-246C7461-14D3-4FE4-9064-3554120704E2Q27000665-55E49F81-BFD7-4339-B8D0-859CA7F740E1Q27008320-B7E80EE8-4A55-4789-A418-94DAEE1C3DD3Q27011524-ABD83DCF-DAF6-4B50-A94E-928E119C46C9Q27014790-DAA3B78F-0C49-4764-82E6-09FF4347C1A6Q27335267-FD45A506-5C54-451C-8C33-61B1BC1F5488Q27335306-ECE5F617-9401-4DE4-BEAD-61D647F1EB50Q27863368-BDE40759-E1F3-4BB0-AEA9-8BBD07D2841EQ28083100-17DD24CE-F294-4BDC-9A6A-EFD81D02CBC3Q28171051-9FF7D9E4-CB9F-4E8D-85E4-28F58963B744Q28191774-ABDE728E-4BFF-4DF8-AF07-33A710F2F1E4Q28203018-FE9EF9CB-B291-4490-AA77-0025EDA540A4Q28212922-8B4A0DA1-BBF2-49AE-8EB1-FDE45ED90342Q28215357-568CFF66-A080-49FD-B5A0-1549E5B6E004Q28217036-163D68C5-23C0-46DD-888B-7978AECF3E48Q28222532-B6FEA1CB-20FB-46B7-8EDF-88E196CB3D0EQ28244228-EF7389C7-2389-404C-B4F6-056F2BEC92BCQ28245060-F4FE761E-D786-4DB8-9EA9-F377C21CDF39Q28245359-C9F1B8DF-A113-462F-A989-5119FD4121DDQ28248690-1EF64778-0377-4B2B-A394-514FC2B167E3Q28249515-1981AAF3-F4F1-4784-A756-F4845233AA54Q28260518-38B573EA-B741-4C43-9131-A33EADBC9311Q28266882-72BF3E28-4A5A-42A8-862C-42EEA644AF01Q28269648-0DCAA43E-2EFE-4B25-9365-2BD12C8E8686Q28276232-1F1489AE-D205-47A6-91E8-D6EFA7473FBCQ28279351-7DBDABA9-3473-4D26-BB73-631FBBFC3EC4Q28287024-692FE955-BD43-40E5-8E5C-19CA5CBF0F3FQ28293875-D9F542DE-E09A-494A-8B76-9170A270B4C6Q28299740-520C76D8-712D-4C95-8B0D-6E0D8E888CC7Q28305656-E09787CE-E7DA-4509-BCAC-E18BFFA55C19Q28657659-F54EB124-D945-4FC0-804B-A97B9FBC2547
P1433
description
Scientific journal
@en-gb
Wissenschaftliche Fachzeitschrift
@de
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
vědecký časopis
@cs
wetenschappelijk tijdschrift van Future Medicine
@nl
науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Pharmacogenomics
@ast
Pharmacogenomics
@da
Pharmacogenomics
@de
Pharmacogenomics
@en
Pharmacogenomics
@en-gb
Pharmacogenomics
@es
Pharmacogenomics
@fi
Pharmacogenomics
@fr
Pharmacogenomics
@it
Pharmacogenomics
@nb
type
label
Pharmacogenomics
@ast
Pharmacogenomics
@da
Pharmacogenomics
@de
Pharmacogenomics
@en
Pharmacogenomics
@en-gb
Pharmacogenomics
@es
Pharmacogenomics
@fi
Pharmacogenomics
@fr
Pharmacogenomics
@it
Pharmacogenomics
@nb
prefLabel
Pharmacogenomics
@ast
Pharmacogenomics
@da
Pharmacogenomics
@de
Pharmacogenomics
@en
Pharmacogenomics
@en-gb
Pharmacogenomics
@es
Pharmacogenomics
@fi
Pharmacogenomics
@fr
Pharmacogenomics
@it
Pharmacogenomics
@nb
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Pharmacogenomics
P123
P1250
P1277
P1476
Pharmacogenomics
@en
P236
P243
P3181
P407
P571
2000-01-01T00:00:00Z